Arcutis appoints Mirum CEO Chris Peetz to board
ARQT•Board appointment announced
Arcutis appointed Christopher “Chris” Peetz to its board, effective July 15, 2026.
- Peetz is co-founder and chief executive officer of Mirum Pharmaceuticals and entrepreneur-in-residence at Frazier Life Sciences.
- He previously led Flashlight Therapeutics as CEO and served as CFO and head of corporate development at Tobira before its sale to Allergan.
